Skip to content
DataLookout
Menu

NCT07608549

FLASH Pilot Phase 1 Safety Study

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary endpoint(s) modified.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoint(s) modified
    • Eligibility criteria expanded, about 16 words
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Incidences and grades of all grade-3-or-higher skin toxicities (according to CTCAE version 6.0) that are attributed to the electron FLASH treatment procedure [FLASH treatment safety and toxicity profile].
Timeframe: 5 years

Arms and interventions

Experimental arm treated with FLASH Radiation TherapyExperimental

In participants with more than one cutaneous lesion requiring treatment, one lesion will be treated with electron FLASH therapy. The prescription dose will be 8 Gray (Gy) in 1 fraction.

Control arm treated with Conventional Radiation TherapyActive comparator

In participants who have more than one cutaneous lesion requiring treatment, the remainder of the lesions not treated with electron FLASH therapy will be treated with conventional electron treatment at the discretion of the treating radiation oncologist.

Devices: IntraOp Mobetron UHDR

Radiation: Linac